PMID: 7017788Mar 1, 1981Paper

An epigenetic model for the origin of cancer

The Quarterly Review of Biology
A C Braun

Abstract

A unifying concept that appears to provide an understanding of cancer as a fundamental scientific problem is presented. This concept, which was initially developed on the basis of experiments using the relatively uncomplicated plant tumor systems, now appears applicable to animal and human tumors as well. Evidence is provided to show that the tumor problem is fundamentally a problem of anomalous cellular differentiation and that the heritable cellular change that underlies the tumorous state is similar to that which underlies cell specialization occurring during the normal course of development in all higher organisms. Both cellular differentiation and tumorigenesis depend for their expression on the persistent activation of select but, in part, different genes (whether normal, foreign, or both) present in the genome of a cell. Since heritable cellular changes of this kind may be induced by physical, chemical, and biological agents of the most diverse type, and since cells may remain totipotent during the time that they exhibit the tumor phenotype, the results reported here suggest that whether the normal or tumor phenotype is expressed is determined by how the genetic information present in a cell is regulated in the cell. Reg...Continue Reading

Citations

Jan 1, 1987·Cancer Metastasis Reviews·J F WhitfieldP R Walker
Dec 17, 2008·Pharmacogenomics·Jennifer E CropleyCatherine M Suter
Feb 1, 1982·Experimental Cell Research·M BignamiS Alemà

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.